← SynDRA

ANAGRELIDE

SynDRA canonical compound SYN0001729 — structure-anchored drug synonym record

Clinical phaseLaunched
Approval statusApproved · Rx/OTC
Primary target(s)PDE3A
Mechanism of actionPhosphodiesterase inhibitor
Indicationmyeloproliferative neoplasms | thrombocythemia
Disease areahematologic malignancy | hematology

All known targets

Mechanisms of action (all sources)

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

Drug classes

ATC classes

Cross-references

Synonyms

Reported adverse events

Look up ANAGRELIDE in the interactive SynDRA portal →